Literature DB >> 20180026

Diabetic cardiomyopathy, causes and effects.

Sihem Boudina1, Evan Dale Abel.   

Abstract

Diabetes is associated with increased incidence of heart failure even after controlling for coronary artery disease and hypertension. Thus, as diabetic cardiomyopathy has become an increasingly recognized entity among clinicians, a better understanding of its pathophysiology is necessary for early diagnosis and the development of treatment strategies for diabetes-associated cardiovascular dysfunction. We will review recent basic and clinical research into the manifestations and the pathophysiological mechanisms of diabetic cardiomyopathy. The discussion will be focused on the structural, functional and metabolic changes that occur in the myocardium in diabetes and how these changes may contribute to the development of diabetic cardiomyopathy in affected humans and relevant animal models.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180026      PMCID: PMC2914514          DOI: 10.1007/s11154-010-9131-7

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  96 in total

Review 1.  Subcellular remodeling and heart dysfunction in chronic diabetes.

Authors:  N S Dhalla; X Liu; V Panagia; N Takeda
Journal:  Cardiovasc Res       Date:  1998-11       Impact factor: 10.787

2.  Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.

Authors:  R Scognamiglio; A Avogaro; D Casara; C Crepaldi; M Marin; M Palisi; R Mingardi; G Erle; G Fasoli; S Dalla Volta
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

3.  Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes.

Authors:  M V Thai; S Guruswamy; K T Cao; J E Pessin; A L Olson
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

4.  Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients.

Authors:  Francisco González-Vílchez; José Ayuela; Miguel Ares; Javier Pi; Luis Castillo; Rafael Martín-Durán
Journal:  Int J Cardiol       Date:  2005-05-11       Impact factor: 4.164

5.  Screening for heart disease in diabetic subjects.

Authors:  Zhi You Fang; Rebecca Schull-Meade; Rodel Leano; Philip M Mottram; Johannes B Prins; Thomas H Marwick
Journal:  Am Heart J       Date:  2005-02       Impact factor: 4.749

6.  Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.

Authors:  Saumya Sharma; Julia V Adrogue; Leonard Golfman; Ivan Uray; John Lemm; Keith Youker; George P Noon; O H Frazier; Heinrich Taegtmeyer
Journal:  FASEB J       Date:  2004-11       Impact factor: 5.191

Review 7.  Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.

Authors:  Sajad A Hayat; Billal Patel; Rajdeep S Khattar; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2004-12       Impact factor: 6.124

8.  Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.

Authors:  Linda R Peterson; Pilar Herrero; Janet McGill; Kenneth B Schechtman; Zulfia Kisrieva-Ware; Donna Lesniak; Robert J Gropler
Journal:  Diabetes       Date:  2007-10-03       Impact factor: 9.461

9.  Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography.

Authors:  Jong-Won Ha; Hyun-Chul Lee; Eun-Seok Kang; Chul-Min Ahn; Jin-Mi Kim; Jeong-Ah Ahn; Se-Wha Lee; Eui-Young Choi; Se-Joong Rim; Jae K Oh; Namsik Chung
Journal:  Heart       Date:  2007-04-20       Impact factor: 5.994

Review 10.  Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome.

Authors:  Heiko Bugger; E Dale Abel
Journal:  Clin Sci (Lond)       Date:  2008-02       Impact factor: 6.124

View more
  260 in total

1.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system.

Authors:  Jaya Krishnan; Carsten Danzer; Tatiana Simka; Josef Ukropec; Katharina Manuela Walter; Susann Kumpf; Peter Mirtschink; Barbara Ukropcova; Daniela Gasperikova; Thierry Pedrazzini; Wilhelm Krek
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

3.  Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.

Authors:  Clothilde Roche; Marie Besnier; Roméo Cassel; Najah Harouki; David Coquerel; Dominique Guerrot; Lionel Nicol; Emmanuelle Loizon; Isabelle Remy-Jouet; Christophe Morisseau; Paul Mulder; Antoine Ouvrard-Pascaud; Anne-Marie Madec; Vincent Richard; Jeremy Bellien
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

4.  Metabolic inflexibility and protein lysine acetylation in heart mitochondria of a chronic model of type 1 diabetes.

Authors:  Shraddha S Vadvalkar; C Nathan Baily; Satoshi Matsuzaki; Melinda West; Yasvir A Tesiram; Kenneth M Humphries
Journal:  Biochem J       Date:  2013-01-01       Impact factor: 3.857

Review 5.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Exposure to Vinyl Chloride and Its Influence on Western Diet-Induced Cardiac Remodeling.

Authors:  Yaqin Liang; Anna L Lang; Jian Zhang; Jing Chen; Kai Wang; Liya Chen; Juliane I Beier; Yan Qian; Lu Cai
Journal:  Chem Res Toxicol       Date:  2018-05-10       Impact factor: 3.739

7.  Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose.

Authors:  Niraj M Bhatt; Miguel A Aon; Carlo G Tocchetti; Xiaoxu Shen; Swati Dey; Genaro Ramirez-Correa; Brian O'Rourke; Wei Dong Gao; Sonia Cortassa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

8.  Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis.

Authors:  Hugo Aguilar; Eduardo Fricovsky; Sang Ihm; Magdalena Schimke; Lisandro Maya-Ramos; Nakon Aroonsakool; Guillermo Ceballos; Wolfgang Dillmann; Francisco Villarreal; Israel Ramirez-Sanchez
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-19       Impact factor: 4.249

9.  Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress.

Authors:  Gábor Koncsos; Zoltán V Varga; Tamás Baranyai; Kerstin Boengler; Susanne Rohrbach; Ling Li; Klaus-Dieter Schlüter; Rolf Schreckenberg; Tamás Radovits; Attila Oláh; Csaba Mátyás; Árpád Lux; Mahmoud Al-Khrasani; Tímea Komlódi; Nóra Bukosza; Domokos Máthé; László Deres; Monika Barteková; Tomáš Rajtík; Adriana Adameová; Krisztián Szigeti; Péter Hamar; Zsuzsanna Helyes; László Tretter; Pál Pacher; Béla Merkely; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-08-12       Impact factor: 4.733

10.  Diabetic cardiomyopathy: ongoing controversies in 2012.

Authors:  P M Seferović; I Milinković; A D Ristić; J P Seferović Mitrović; K Lalić; A Jotić; V Kanjuh; N Lalić; B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.